Hydrocodone Polistirex And Chlorpheniramine Polistirex Suspension, Extended Release
Product Images NDC 27808-086

Product Visual Gallery

This gallery contains 8 technical images submitted to the FDA as part of the official labeling for Hydrocodone Polistirex And Chlorpheniramine Polistirex (NDC 27808-086). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Cranbury Pharmaceuticals, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Structure 1 (Hydrocodone Polistirex And Chlorpheniramine Polist 1)

Chemical structure diagram showing two distinct molecular structures: the polymeric structure of the polistirex component depicted by repeating styrene sulfonate units, and the complex bicyclic structure of hydrocodone. This image represents the chemical structures related to Hydrocodone Polistirex and Chlorpheniramine Polistirex in the extended-release suspension formulation.*

FDA Label Image

Structure 2 (Hydrocodone Polistirex And Chlorpheniramine Polist 2)

Chemical structure diagram showing the molecular composition of Hydrocodone Polistirex and Chlorpheniramine Polistirex, the active ingredients in this extended-release oral suspension.*

FDA Label Image

Cup (Hydrocodone Polistirex And Chlorpheniramine Polist 3)

An illustration of a measuring cup with volume markings indicating 0.5 teaspoon equivalent to 2.5 mL and 1 teaspoon equivalent to 5 mL, used for accurate oral dosing of liquid medications.*

FDA Label Image

4 Oz. Label (Hydrocodone Polistirex And Chlorpheniramine Polist 4)

Label for Hydrocodone Polistirex and Chlorpheniramine Polistirex extended-release suspension equivalent to 10 mg hydrocodone bitartrate and 8 mg chlorpheniramine maleate per 5 mL. It indicates 12-hour dosing, contraindication for children under 6 years, and prescription only. The bottle size shown is 4 fl. oz. (115 mL). Manufactured by Tris Pharma, Inc., Monmouth Junction, NJ.*

FDA Label Image

4 Oz. Carton (Hydrocodone Polistirex And Chlorpheniramine Polist 5)

Label for Hydrocodone Polistirex and Chlorpheniramine Polistirex Extended-Release Suspension, equivalent to 10 mg hydrocodone bitartrate and 8 mg chlorpheniramine maleate per 5 mL, 4 fl. oz. (115 mL) bottle by Cranbury Pharmaceuticals, LLC. The label includes dosing instructions, contraindications for children under 6 years, warnings, storage instructions, and pharmacist directions to dispense the Medication Guide. The product is Rx only.*

FDA Label Image

16 Oz Label (Hydrocodone Polistirex And Chlorpheniramine Polist 6)

Label for Hydrocodone Polistirex and Chlorpheniramine Polistirex Extended-Release Suspension, oral suspension with 10 mg hydrocodone bitartrate and 8 mg chlorpheniramine maleate per 5 mL. It is a 12-hour dosing liquid formulation, supplied in a 16 fl. oz. (473 mL) bottle by Tris Pharma, Inc. Label includes dosage instructions, warnings, storage information, and a pharmacy dispensing note. Nonalcoholic formula with a shake well instruction is indicated.*

FDA Label Image

3 Oz Label (Hydrocodone Polistirex And Chlorpheniramine Polist 7)

Label for Hydrocodone Polistirex and Chlorpheniramine Polistirex extended-release suspension, 10 mg hydrocodone bitartrate and 8 mg chlorpheniramine maleate per 5 mL, 12-hour dosing. The 70 mL oral suspension is nonalcoholic and labeled for prescription use, manufactured by Cranbury Pharmaceuticals, LLC. The label includes directions to shake well, storage instructions, and warnings.*

FDA Label Image

3 Oz Carton (Hydrocodone Polistirex And Chlorpheniramine Polist 8)

Hydrocodone Polistirex and Chlorpheniramine Polistirex Extended-Release Suspension carton label, equivalent to 10 mg hydrocodone bitartrate and 8 mg chlorpheniramine maleate per 5 mL, labeled for 12-hour dosing. The oral suspension is in a 70 mL bottle, prescription only, manufactured by Tris Pharma, Inc. The label includes dosing instructions, warnings, storage conditions, and pharmacist dispensing information.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.